These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 20702625)
21. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. LeMaoult J; Zafaranloo K; Le Danff C; Carosella ED FASEB J; 2005 Apr; 19(6):662-4. PubMed ID: 15670976 [TBL] [Abstract][Full Text] [Related]
22. Crystallization and preliminary X-ray analysis of the low-affinity complex between human leukocyte antigen-G (HLA-G) and leukocyte Ig-like receptor B2 (LILRB2). Shiroishi M; Maenaka K Protein Pept Lett; 2009; 16(4):447-9. PubMed ID: 19356145 [TBL] [Abstract][Full Text] [Related]
23. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Navarro F; Llano M; Bellón T; Colonna M; Geraghty DE; López-Botet M Eur J Immunol; 1999 Jan; 29(1):277-83. PubMed ID: 9933109 [TBL] [Abstract][Full Text] [Related]
24. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. Colonna M; Navarro F; Bellón T; Llano M; García P; Samaridis J; Angman L; Cella M; López-Botet M J Exp Med; 1997 Dec; 186(11):1809-18. PubMed ID: 9382880 [TBL] [Abstract][Full Text] [Related]
25. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. Allan DS; Colonna M; Lanier LL; Churakova TD; Abrams JS; Ellis SA; McMichael AJ; Braud VM J Exp Med; 1999 Apr; 189(7):1149-56. PubMed ID: 10190906 [TBL] [Abstract][Full Text] [Related]
26. Special organization of the HLA-G protein on the cell surface. Gonen-Gross T; Gazit R; Achdout H; Hanna J; Mizrahi S; Markel G; Horejsí V; Mandelboim O Hum Immunol; 2003 Nov; 64(11):1011-6. PubMed ID: 14602229 [TBL] [Abstract][Full Text] [Related]
27. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145 [TBL] [Abstract][Full Text] [Related]
28. HLA-G level on monocytoid dendritic cells correlates with regulatory T-cell Foxp3 expression in liver transplant tolerance. Castellaneta A; Mazariegos GV; Nayyar N; Zeevi A; Thomson AW Transplantation; 2011 May; 91(10):1132-40. PubMed ID: 21423069 [TBL] [Abstract][Full Text] [Related]
29. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts. Zhang W; Liang S; Wu J; Horuzsko A Transplantation; 2008 Oct; 86(8):1125-34. PubMed ID: 18946352 [TBL] [Abstract][Full Text] [Related]
30. Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells. Gregori S; Magnani CF; Roncarolo MG Hum Immunol; 2009 Dec; 70(12):966-9. PubMed ID: 19664675 [TBL] [Abstract][Full Text] [Related]
31. Multiplex bead-based immunoassay for the free soluble forms of the HLA-G receptors, ILT2 and ILT4. Wu CL; Svendsen SG; Riviere A; Desgrandchamps F; Carosella ED; LeMaoult J Hum Immunol; 2016 Sep; 77(9):720-6. PubMed ID: 26874236 [TBL] [Abstract][Full Text] [Related]
32. HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. Jones DC; Kosmoliaptsis V; Apps R; Lapaque N; Smith I; Kono A; Chang C; Boyle LH; Taylor CJ; Trowsdale J; Allen RL J Immunol; 2011 Mar; 186(5):2990-7. PubMed ID: 21270408 [TBL] [Abstract][Full Text] [Related]
33. Leukocyte Ig-Like receptor B1 restrains dendritic cell function through increased expression of the NF-κB regulator ABIN1/TNIP1. Khanolkar RC; Kalogeropoulos M; Lawrie A; Roghanian A; Vickers MA; Young NT J Leukoc Biol; 2016 Oct; 100(4):737-746. PubMed ID: 27129285 [TBL] [Abstract][Full Text] [Related]
34. Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes. Le Friec G; Laupèze B; Fardel O; Sebti Y; Pangault C; Guilloux V; Beauplet A; Fauchet R; Amiot L Hum Immunol; 2003 Aug; 64(8):752-61. PubMed ID: 12878353 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of iNKT Cells by the HLA-G-ILT2 Checkpoint and Poor Stimulation by HLA-G-Expressing Tolerogenic DC. Wu CL; Caumartin J; Amodio G; Anna F; Loustau M; Gregori S; Langlade-Demoyen P; LeMaoult J Front Immunol; 2020; 11():608614. PubMed ID: 33505397 [TBL] [Abstract][Full Text] [Related]
36. HLA-G and HLA-E in patients with juvenile idiopathic arthritis. Prigione I; Penco F; Martini A; Gattorno M; Pistoia V; Morandi F Rheumatology (Oxford); 2011 May; 50(5):966-72. PubMed ID: 21186170 [TBL] [Abstract][Full Text] [Related]
37. Natural killer cell activation and inhibition by receptors for MHC class I. López-Botet M; Bellón T Curr Opin Immunol; 1999 Jun; 11(3):301-7. PubMed ID: 10375552 [TBL] [Abstract][Full Text] [Related]
38. Mass Cytometry Analysis Reveals Complex Cell-State Modifications of Blood Myeloid Cells During HIV Infection. Coindre S; Tchitchek N; Alaoui L; Vaslin B; Bourgeois C; Goujard C; Lecuroux C; Bruhns P; Le Grand R; Beignon AS; Lambotte O; Favier B Front Immunol; 2019; 10():2677. PubMed ID: 31824485 [TBL] [Abstract][Full Text] [Related]
39. HLA-G in the human thymus: a subpopulation of medullary epithelial but not CD83(+) dendritic cells expresses HLA-G as a membrane-bound and soluble protein. Mallet V; Blaschitz A; Crisa L; Schmitt C; Fournel S; King A; Loke YW; Dohr G; Le Bouteiller P Int Immunol; 1999 Jun; 11(6):889-98. PubMed ID: 10360962 [TBL] [Abstract][Full Text] [Related]